You are here

Coronary Intervention & Surgery

 

A cross-sectional study of nearly 1,300 patients revealed Chinese physicians systematically overestimate the severity of coronary stenosis, perhaps even more so than in the United States, likely leading to many patients being inappropriately treated with percutaneous coronary intervention (PCI).

The risk of another heart attack following percutaneous coronary intervention (PCI) was twice as likely to originate from a previously untreated lesion versus the stented lesion, according to a study of a large Swedish cohort published in the Journal of the American Heart Association.

Patients are significantly more likely to die within one year of coronary artery bypass graft (CABG) surgery or PCI in New York state than in England where the procedures are roughly four times cheaper, according to a study in Open Heart.

Temporarily cooling part of the heart during myocardial infarction (MI) and again immediately after angioplasty may reduce damage to the heart, said a cardiologist who participated in the first in-human study of the technique.

Charles E. Chambers, MD, spoke with Cardiovascular Business about the risks of radiation exposure to interventional cardiologists and potential solutions.

 

Recent Headlines

First Word: A Stent is a Stent is a Stent...or is It?

Drug-eluting stents (DES) would not be used if they did not benefit patients. To that end, vendors conduct clinical studies to show that their product is equal to or better than a previous-generation product or a current competitor’s product.

Planning for the Ideal Cath Lab Requires the Multidisciplinary Approach

Planning and creating the best cath lab for your facility and market requires a wide range of considerations, from current and future business patterns to space design to workflow and communication concerns. A good plan that includes input from all the relevant stakeholders goes a long way toward a successful long-term venture.

Roundtable Discussion: The Big 4 Stentmakers

Cardiovascular Business invited representatives from the four major stent manufacturers to discuss the challenges and future outlook for drug-eluting stents (DES).

Can Off-Hour D2B Times be Reduced Without Breaking the Bank

The persistent discrepancy between the door-to-balloon times of on-hours versus off-hours in STEMI patients undergoing PCI procedures can be solved through cost-effective means; however, some argue that an expensive and complex pre-activation program is needed to bring off-hour times in line with those of on-hours.

Cath Lab Exposé: What it takes to keep patients, profits, and referring docs in today's changing landscape

Cardiac cath labs operate in an increasingly challenging environment, contending with a variety of clinical, demographic, regulatory and competitive factors.

Wracked by Bad Press, Drug-Eluting Stents Start Their Comeback

The utilization of drug-eluting stents may be poised for a comeback based on recent clinical studies that found they have value despite some risks. Industry analysts, however, suggest that there their usage has plateaued and they can not maintain their initial groundbreaking sales. 

Coronary Intervention: Financial Factors Facing Cath Labs

Recent trial results, multidetector CT and new and more uses for the services and equipment of the traditional cardiac catheterization lab are impacting the bottom line of facilities across the country. These and more factors may have temporarily decreased cath lab procedures, but experts in the field predict recovery—albeit a changing face for the cath lab.

Strategies to Trim Door-to-Balloon Time

Door-to-balloon time (D2B) is a critical cardiac quality indicator. As a whole, U.S. hospitals are doing fairly well with other quality indicators, says Betsy Bradley, PhD, professor of public health at Yale University in New Haven, Conn., but D2B time is a challenge for many sites. Here are some prescriptions to break the 90-minute barrier.

The Cardiac Cath Lab in Evolution

Cardiac catheterization labs across the country are evolving. Changes in types and volumes of procedures combined with an increasingly competitive environment and reimbursement cuts are forcing cath labs to adapt and fine-tune their management strategies. What brings success? Diversifying into EP and peripheral vascular procedures, tightly managing and even consigning pricey inventory such as drug-eluting stents, cross-training staff, and ensuring high flexibility.

Pages